Literature DB >> 16722236

The role of SNARE proteins in trafficking and function of neurotransmitter transporters.

M W Quick1.   

Abstract

The SNARE hypothesis of vesicle fusion proposes that a series of protein-protein interactions governs the delivery of vesicles to various membrane targets such as the Golgi network and the plasma membrane. Key players in this process include members of the syntaxin family of membrane proteins. The first member identified in this family, syntaxin 1A, plays an essential role in the docking and fusion of neurotransmitter-containing vesicles to the presynaptic membrane of neurons. Syntaxin 1A and other syntaxin family members have also been shown to interact with, and directly regulate, a variety of ion channels. More recently, the family of plasma membrane neurotransmitter transporters, proteins that function in part to control transmitter levels in brain, have been shown to be direct targets of syntaxin 1A regulation. This regulation involves both the trafficking of transporters as well as the control of ion and transmitter flux through transporters. In this chapter, the functional effects of syntaxin-transporter interactions are reviewed, and how such interactions may regulate neuronal signaling are considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16722236     DOI: 10.1007/3-540-29784-7_9

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  21 in total

Review 1.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake.

Authors:  Dmitry M Mebel; Jovi C Y Wong; Yifei J Dong; Stephanie L Borgland
Journal:  Eur J Neurosci       Date:  2012-06-20       Impact factor: 3.386

3.  Substrate-mediated regulation of gamma-aminobutyric acid transporter 1 in rat brain.

Authors:  Jia Hu; Michael W Quick
Journal:  Neuropharmacology       Date:  2007-10-07       Impact factor: 5.250

4.  Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: live-cell imaging using total internal reflection fluorescence microscopy.

Authors:  Cheryse A Furman; Rong Chen; Bipasha Guptaroy; Minjia Zhang; Ronald W Holz; Margaret Gnegy
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

5.  Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission.

Authors:  Lucia Carvelli; Randy D Blakely; Louis J DeFelice
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

6.  Rab 11 regulates constitutive dopamine transporter trafficking and function in N2A neuroblastoma cells.

Authors:  Cheryse A Furman; Charles B Lo; Stephanie Stokes; Jose A Esteban; Margaret E Gnegy
Journal:  Neurosci Lett       Date:  2009-07-22       Impact factor: 3.046

7.  Chronic adjunction of 1-deoxynojirimycin protects from age-related behavioral and biochemical changes in the SAMP8 mice.

Authors:  Gui-Hai Chen; Jing-Jing Tong; Fang Wang; Xue-Qin Hu; Xue-Wei Li; Fei Tao; Zhao-Jun Wei
Journal:  Age (Dordr)       Date:  2015-09-23

8.  Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.

Authors:  Francesca Binda; Concetta Dipace; Erica Bowton; Sabrina D Robertson; Brandon J Lute; Jacob U Fog; Minjia Zhang; Namita Sen; Roger J Colbran; Margaret E Gnegy; Ulrik Gether; Jonathan A Javitch; Kevin Erreger; Aurelio Galli
Journal:  Mol Pharmacol       Date:  2008-07-10       Impact factor: 4.436

9.  Plasmalemmal and vesicular gamma-aminobutyric acid transporter expression in the developing mouse retina.

Authors:  Chenying Guo; Salvatore L Stella; Arlene A Hirano; Nicholas C Brecha
Journal:  J Comp Neurol       Date:  2009-01-01       Impact factor: 3.215

10.  Robust syntaxin-4 immunoreactivity in mammalian horizontal cell processes.

Authors:  Arlene A Hirano; Johann Helmut Brandstätter; Alejandro Vila; Nicholas C Brecha
Journal:  Vis Neurosci       Date:  2007-07-20       Impact factor: 3.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.